PackGene at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

PackGene brings 4 presentations to ESGCT 2026 in Hamburg. Its contribution covers the testing and reference materials behind AAV manufacturing, from replication-competent AAV standards to rapid mycoplasma screening and capsid content analysis. One project uses a liver-detargeted AAV to deliver a bispecific T cell engager more safely.

OrganizationESGCT 2026 Attendance
PackGene
Houston, TX
CDMOs & CROs
Contract research and manufacturing of plasmid DNA, AAV, lentiviral vectors and mRNA-LNP, from research grade to GMP production.
Poster
Wed Oct 28
1:30pm–3:30pm
Development of serotype-specific rcAAV reference materials for sensitive and specific AAV manufacturing release testing
AAVs / non integrative vectors
Poster
Wed Oct 28
1:30pm–3:30pm
Rapid extraction-free dual-target RT-qPCR workflow for high-sensitivity mycoplasma testing in cell and gene therapy products
AAVs / non integrative vectors
Poster
Thu Oct 29
2:00pm–4:00pm
A liver-detargeted, tissue-selective AAV strategy for safer bispecific T-cell engager therapy
AAVs / non integrative vectors
Poster
Thu Oct 29
2:00pm–4:00pm
Native AAV reference standards for mass photometry-based capsid content analysis
AAVs / non integrative vectors

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from PackGene

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction